Cargando…
Isoalantolactone suppresses gallbladder cancer progression via inhibiting the ERK signalling pathway
CONTEXT: Gallbladder cancer (GBC) is the most common malignant tumour of the biliary tract. Isoalantolactone (IAL), an active sesquiterpene lactone compound isolated from the roots of Inula helenium L. (Asteraceae), has antitumour effects. OBJECTIVE: This study investigates the effects of IAL on GBC...
Autores principales: | Lv, Xingyu, Lin, Yuqi, Zhu, Xi, Cai, Xiujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064832/ https://www.ncbi.nlm.nih.gov/pubmed/36994917 http://dx.doi.org/10.1080/13880209.2023.2191645 |
Ejemplares similares
-
Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation
por: Fan, Yonggang, et al.
Publicado: (2015) -
Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
por: Rasul, Azhar, et al.
Publicado: (2013) -
Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway
por: Zhang, Chaoxiong, et al.
Publicado: (2021) -
Isoalantolactone Inhibits UM-SCC-10A Cell Growth via Cell Cycle Arrest and Apoptosis Induction
por: Wu, Minjun, et al.
Publicado: (2013) -
Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
por: Chun, Jaemoo
Publicado: (2023)